Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

Objectives: RECORDAF is the first worldwide, prospective, observational survey of management of atrial fibrillation (AF) in unselected, community-based patients.

Background: Primary outcomes were therapeutic success and clinical outcomes associated with rhythm-control and rate-control strategies.

Methods: Patients with recent-onset AF were included (n = 5,604).

Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.

Background: The Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation (RecordAF) study is the first worldwide, prospective, survey of real-life management of atrial fibrillation (AF) in recently diagnosed patients (n = 5604) with a 1-year follow-up.

Hypothesis: Surveys of AF management have identified a divergence between guidelines and clinical practice, and an overinterpretation of guidelines in low-risk patients.

Methods: : Physicians' theoretical approaches to rhythm and rate control were investigated using a pre-study questionnaire.